News Release

Zubair W. Baloch, MD, PhD, a professor of Pathology and Laboratory Medicine, has received the American Society of Cytopathology 2022 President's Award in recognition of his contributions to the society. He has been a member since 1997 and previously served on the executive board and the chair of the Scientific Program Committee.


C├ęsar de la Fuente
César de la Fuente, PhD

César de la Fuente, PhD, a Presidential Assistant Professor of Psychiatry, Microbiology, Chemical and Biomolecular Engineering, and Bioengineering, has been honored with the Molecules 2022 Young Investigator Award on Nov. 3, 2022. De la Fuente was selected for his pioneering research work across antibiotic discovery, synthetic biology, and computational biology.

 

 

 

 

 


Virginia Man-Yee Lee
Virginia Man-Yee Lee, PhD

Virginia Man-Yee Lee, PhD, a professor of Pathology and Laboratory Medicine, has been named a 2022 Clarivate Citation Laureate for her contribution to the identification of TDP-43, a pathological signature of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, and for other contributions to the study of neurodegenerative diseases. Citation Laureates are selected for their highly cited and influential research, based on Web of Science™ citation data.

 

 

 

 

 


Bruce Levine
Bruce Levine, PhD

Bruce Levine, PhD, a professor of Pathology and Laboratory Medicine, has been selected as the Precision Medicine World Conference 2023 Luminary Award Honoree for Gene-modified Cell Therapies for his pioneering work in cancer immunotherapies that led to the first FDA-approved gene therapy for leukemia and lymphoma. The award recognizes the recent contributions of prominent figures who have accelerated precision medicine into the clinic.

 

 

 

 

 


Donald L. Siegel
Donald L. Siegel, MD, PhD

Donald L. Siegel, MD, PhD, a professor of Pathology and Laboratory Medicine, was named the 2022 Inductee of the National Blood Foundation (NBF) Hall of Fame from the Association for the Advancement of Blood & Biotherapies (AABB) in honor of his accomplishments in immunohematology, hemostasis/thrombosis, autoimmunity, and oncology since receiving an AABB Foundation grant in 1991. The award recognizes grant recipients who leveraged their early-career grant funding into successful careers in transfusion medicine or biotherapies and who demonstrated exemplary leadership within the field.

 

 

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $9.9 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $546 million awarded in the 2021 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is powered by a talented and dedicated workforce of more than 47,000 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2021, Penn Medicine provided more than $619 million to benefit our community.

Share This Page: